Lisa M Sullivan

Summary

Affiliation: The Children's Hospital of Philadelphia
Country: USA

Publications

  1. pmc Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
    Lisa M Sullivan
    Department of Pathology and Laboratory Medicine, The Children s Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA
    Mod Pathol 26:385-92. 2013
  2. pmc Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors
    Lisa M Sullivan
    Department of Pathology and Laboratory Medicine, Children s Hospital of Philadelphia, Philadelphia, PA, USA
    Am J Surg Pathol 36:73-80. 2012
  3. doi request reprint Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases
    Elaine S Chan
    Department of Pathology and Laboratory Medicine, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Pediatr Dev Pathol 16:272-7. 2013
  4. doi request reprint Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors
    Margaret J Dougherty
    Division of Human Genetics, Department of Pediatrics, The Children s Hospital of Philadelphia, Philadelphia, PA, USA
    Cancer Genet 205:42-54. 2012
  5. doi request reprint Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins
    Sriram Venneti
    Division of Neuropathology, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Am J Surg Pathol 35:1463-72. 2011

Collaborators

  • Alexander R Judkins
  • Sriram Venneti
  • Elaine S Chan
  • Margaret J Dougherty
  • Bruce R Pawel
  • Diana A Corao
  • Pierre Russo
  • Mariarita Santi
  • Luanne M Wainwright
  • Jaclyn A Biegel
  • Hakon Hakonarson
  • Laura S Tooke

Detail Information

Publications5

  1. pmc Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
    Lisa M Sullivan
    Department of Pathology and Laboratory Medicine, The Children s Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA
    Mod Pathol 26:385-92. 2013
    ..Given the high percentage of SMARCB1 alterations in epithelioid sarcoma, these findings argue against using SMARCB1 gene deletion as a tool in distinguishing them from malignant rhabdoid tumors...
  2. pmc Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors
    Lisa M Sullivan
    Department of Pathology and Laboratory Medicine, Children s Hospital of Philadelphia, Philadelphia, PA, USA
    Am J Surg Pathol 36:73-80. 2012
    ..Although CLDN6 is expressed in both AT/RTs and MRTs, it is not a specific biomarker as it is expressed in a variety of other pediatric CNS and soft tissue tumors...
  3. doi request reprint Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases
    Elaine S Chan
    Department of Pathology and Laboratory Medicine, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Pediatr Dev Pathol 16:272-7. 2013
    ..0001) in addition to negative INI1/BAF47/SMARCB1 staining to differentiate atypical teratoid rhabdoid tumors from other high-grade pediatric brain tumors...
  4. doi request reprint Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors
    Margaret J Dougherty
    Division of Human Genetics, Department of Pediatrics, The Children s Hospital of Philadelphia, Philadelphia, PA, USA
    Cancer Genet 205:42-54. 2012
    ..Based on our experience in the last 2 1/2 years, we suggest that SNP array analysis can be used as a first tier clinical test for the majority of pediatric solid tumors...
  5. doi request reprint Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins
    Sriram Venneti
    Division of Neuropathology, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Am J Surg Pathol 35:1463-72. 2011
    ..This study underscores similarities between MRTs and stem cells and may help elucidate common biologic pathways that could serve in advancing more effective therapeutic strategies to treat MRTs...